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After many years of experimental studies we
obtained permission in 1988 from the Research
Ethical Committee of the Medical Academy in
Warsaw to perform a series of therapeutic
transplantations of human foetal mesencephalic
tissue into the brains of patients with Parkinson’s
disease (PD). We followed NECTAR ethical
guidelines for the use of foetal material for
transplantation purposes.
Implantations of human foetal dopaminergic
cells taken from the ventral part of one mesen-
cephalon of 11-12 week-old foetuses into the
head of the caudate nucleus were performed in
three PD patients aged 48, 53, and 50 years,
respectively. All patients had been suffering
from the severe form of PD for about 10-15
years (stage 4/5 according to Hoehn & Yahr
scale) with bradykinesia, rigidity and tremor as
the main symptoms. Long-lasting L-dopa ther-
apy resulted in side effects with "ON-OFF"
syndrome and dyskinesias.
The operations were performed according to
Madrazo’s microsurgical technique. Implanta-
tion of foetal tissue into the caput of the caudate
nucleus was carried out by means of an instru-
ment devised by Zabek. One day before the
operation immunosuppressive therapy was
introduced and continued for 6 postoperative
months. A detailed clinical examination was
performed before and every 3 months after the
operation according to the battery of inter-
national tests recommended by CAPIT.
The patients were under post-operational
observation lasting 30, 20 and 12 months,
respectively. Improvement was observed in all
patients starting between 3 and 6 months after
operation until the present. Significant increases
in movement speed for repeated pronation-
supination, finger dexterity and foot lifting tests
were found. The speed of walking also increased
with decreased rigidity. The "OFF" phase during
the day became shorter and less severe; dys-
kinesias were markedly reduced. Some of the
results obtained during the 30-month recovery of
patient No. 1 are presented in the following
Figure and Table.
It seems that the 30 and 20 months recovery
of patients No. 1 and No. 2, respectively, is a
long enough term of observation to recommend
the benefits of intracerebral transplantations in
hopeless patients, who have already exhausted
all the other therapeutic possibilities and are
conscious that the course of the disease will
slowly progress and deteriorate. In all patients
recovery was not observed before 3 months after
transplantation. Probably, this period of time is
necessary for sprouting and creation of a
neuronal network between the graft and the host
brain. The improvement increased between the
3rd and 6th months, was still continuing during
the following months and reached a stable stage
at 9-12 months after the transplantation.
Despite the fact that the doses of L-dopa
could not be decreased we observed that the
duration of dyskinesias and OFF phase de-
creased significantly in all cases. It is also worth
noting that despite the unilateral DA cell im-
plantation, bilateral motor improvement was
found. Our results indicate that foetal grafting
seems to be a valuable method for selected
parkinsonian patients. However, we should
never forget that at present neural transplanta-
tion is still an experimental approach.
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